全球血管成形术用气球市场规模（按产品类型、应用、最终用户、区域范围和预测）

血管成形术用气球的市场规模与预测

预计 2024 年血管成形术用气球市值将达 20.5 亿美元，2031 年将达到 26.2 亿美元，2024 年至 2031 年的复合年增长率为 3.43%。

血管成形术用气球是用于血管成形术的专用医疗设备。血管成形术是一种用于打开狭窄或阻塞的血管（尤其是动脉）并促进血流的技术。血管成形术用气球最典型的用途是治疗冠状动脉疾病。冠状动脉疾病是指向心臟供血的动脉因斑块（由脂肪、胆固醇和其他化学物质混合物）的积聚而收缩。

血管成形术用气球是治疗冠状动脉疾病的重要医疗设备。冠状动脉疾病是指由心臟供血的动脉收缩或阻塞所引发的疾病。血管成形术用气球最常见的用途是经经皮冠状动脉扩张术(PTCA)，即将一根尖端带有球囊的导管插入冠状动脉狭窄区域。

随着医疗技术的进步以及对改善心血管治疗患者预后的日益重视，预计血管成形术用气球经皮血管成形术用气球越来越复杂，并根据每位患者的个性化需求进行客製化。

全球血管成形术用气球市场动态

影响全球血管成形术用气球市场的关键市场动态是：

关键市场驱动因素

心血管疾病盛行率上升：血管成形术用气球市场最重要的驱动因素之一是全球心血管疾病 (CVD) 盛行率的上升。不良饮食习惯、久坐不动的生活方式以及人口老化导致冠状动脉疾病、心臟病和动脉粥样硬化的发病率不断上升。

转向微创手术：医学界对微创手术的需求日益增长，而血管成形术正是顺应这一趋势的重要治疗方法之一。微创手术之所以受到青睐，是因为与标准的开胸心臟手术相比，它们通常恢復时间更短、疼痛更少、併发症风险更低。血管成形术是一种微创手术，将带有球囊的导管插入血管，到达阻塞部位，通常在局部麻醉下进行。

球囊设计技术进步：血管成形术用气球设计和功能的不断改进也是市场发展的关键驱动力。药物涂层球囊能够输送药物，防止动脉再次收缩，显着提高了血管成形术的成功率。此外，用于治疗疑难病变或钙化病变的专用球囊的开发，也增加了受益于血管成形术的患者数量。

主要挑战

球囊破裂风险：血管成形术用气球最大的担忧之一是治疗过程中球囊破裂的可能性。如果球囊充气超过斑块，就可能发生破裂。破裂可能导致动脉损伤，需要进一步治疗，甚至有心臟病发作的风险。

复杂病变导航困难：血管成形术球囊必须在冠状动脉内导航才能到达阻塞源头。复杂病变，例如弯曲、高度钙化或曲折病变，会造成重大障碍。在这些情况下，球囊可能难以导航或充气不均匀，导致治疗不彻底或无效。

血管再阻塞和阻塞復发：血管成形术后，治疗动脉有再次阻塞的风险。这可能是由于治疗部位疤痕组织形成或斑块再生所致。血管再阻塞是常见问题，可能需要重复治疗或额外治疗，例如置入术。

主要趋势

技术进步：血管成形术用气球产业已取得重大技术进步，并催生出高度专业化和高效的设备。药物涂层球囊 (DCB) 和为提高性能而设计的尖端材料就是创新的典范。药物涂层球囊在治疗过程中将药物直接输送至动脉壁，旨在预防血管再阻塞血管再阻塞）。这项技术可改善血管成形术后患者的长期预后。

心血管疾病发生率上升：心血管疾病（CVD）发生率的上升推动了对血管成形术用气球的需求。由于不良饮食、缺乏运动和肥胖率上升等生活方式因素，冠状动脉疾病和周边动脉疾病等心血管疾病的发生率日益上升。

专注于微创手术：医学界对微创手术的需求日益增长，而血管成形术用气球恰好契合了这一趋势。微创手术相比标准手术方法具有许多优势，包括恢復时间更短、潜在併发症更少以及术后疼痛更少。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第三章 市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章血管成形术用气球市场（依产品类型）

• 普通气球
• 切割/球囊导管
• 药物释放型球囊（DEB）

第五章血管成形术用气球市场（依应用）

• 冠状动脉成形术
• 週边血管成形术

第六章血管成形术用气球市场（依最终用户）

• 医院
• 门诊手术中心（ASC）
• 心导管实验室

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市占率分析

第十章：公司简介

• Medtronic
• Boston Scientific Corporation
• Cordis（Cardinal Health）
• Terumo Corporation
• BIOTRONIK

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Angioplasty Balloons Market Size and Forecast

Angioplasty Balloons Market size was valued at USD 2.05 Billion in 2024 and is projected to reach USD 2.62 Billion by 2031, growing at a CAGR of 3.43% from 2024 to 2031.

Angioplasty balloons are specialized medical devices used in angioplasty, a technique that opens restricted or clogged blood vessels, particularly arteries, to enhance blood flow. The most typical application for angioplasty balloons is to treat coronary artery disease which occurs when the arteries that deliver blood to the heart constrict owing to plaque buildup a mixture of fat, cholesterol, and other chemicals.

Angioplasty balloons are critical medical equipment used to treat coronary artery disease which develops when the blood arteries that feed blood to the heart constrict or get blocked. The most prevalent application for angioplasty balloons is percutaneous transluminal coronary angioplasty (PTCA). This treatment involves inserting a balloon-tipped catheter into a constricted portion of the coronary artery.

The future usage of angioplasty balloons is expected to change dramatically driven by advances in medical technology and a rising emphasis on improving patient outcomes in cardiovascular treatment. Angioplasty balloons which are used to unblock blocked or restricted blood arteries during percutaneous coronary interventions (PCI) are becoming more complex and adapted to individual patient needs.

Global Angioplasty Balloons Market Dynamics

The key market dynamics that are shaping the global angioplasty balloons market include:

Key Market Drivers:

Rising Cardiovascular Disease Incidence: One of the most important drivers of the angioplasty balloons market is the global increase in cardiovascular illnesses (CVDs). Coronary artery disease, heart attacks, and atherosclerosis are on the rise as a result of poor diets, sedentary lifestyles, and an aging population.

Shift towards Minimally Invasive Procedures: In the medical world, there is an increasing demand for minimally invasive procedures, and angioplasty is one of the important treatments that fits this trend. Minimally invasive operations are preferred because they often have shorter recovery times, less pain, and a lower risk of problems than standard open-heart surgeries. Angioplasty which includes threading a balloon-tipped catheter through the blood vessels to the site of the blockage is a less invasive procedure that may often be done under local anesthesia.

Technological Advancements in Balloon Design: Constant improvements in the design and functionality of angioplasty balloons are another important market driver. Drug-coated balloons which deliver medication to assist prevent arteries from constricting again have considerably improved angioplasty outcomes. Furthermore, the development of specialty balloons such as those intended for use in difficult or calcified lesions has increased the number of patients who can benefit from angioplasty.

Key Challenges:

Risk of Balloon Rupture: One of the biggest issues with angioplasty balloons is the possibility of balloon rupture during the treatment. This can happen if the balloon is inflated above its intended pressure limit or if it comes into contact with a very hard or calcified artery plaque. A rupture can result in consequences such as arterial damage, the necessity for additional treatments, and even the danger of a heart attack.

Difficulty Navigating Complex Lesions: Angioplasty balloons must travel through the coronary arteries to reach the source of the obstruction. Complex lesions such as those with substantial curvature, extensive calcification, or tortuous paths might present significant obstacles. In such circumstances, the balloon may struggle to move through or may not inflate evenly resulting in inadequate or inefficient treatment.

Restenosis and Recurrent Blockages: Following an angioplasty operation, there is a danger that the treated artery will become blocked again. This could be due to the creation of scar tissue or the regrowth of plaque at the treatment location. Restenosis is a common problem that requires repeat treatments or extra interventions like stenting.

Key Trends:

Technological Improvements: The angioplasty balloon industry is experiencing tremendous technological improvements, resulting in the creation of highly specialized and effective devices. Drug-coated balloons (DCBs) and cutting-edge materials designed to improve performance are examples of innovations. Drug-coated balloons are intended to deliver medication directly to the artery walls during the process, preventing restenosis, which is the re-narrowing of the artery following therapy. This technology improves patients' long-term results after angioplasty.

Rise in Cardiovascular Illnesses: The increasing frequency of cardiovascular illnesses (CVDs) is driving up demand for angioplasty balloons. CVDs including coronary artery disease and peripheral artery disease are becoming increasingly prevalent as a result of lifestyle factors such as poor food, lack of exercise, and rising obesity rates.

Focus on Less Invasive Procedures: In the medical world, there is a rising demand for less invasive procedures, and angioplasty balloons fit right in with this trend. Minimally invasive procedures provide various advantages over standard surgical methods including quicker recovery times, a lower chance of complications, and less post-operative pain.

Global Angioplasty Balloons Market Regional Analysis

Here is a more detailed regional analysis of the global angioplasty balloons market:

North America:

The high prevalence of cardiovascular disease and an aging population are the primary drivers of the North American angioplasty balloons market. The United States leads the regional market due to its advanced healthcare infrastructure and high healthcare spending. The rising incidence of coronary artery disease (CAD) and peripheral artery disease (PAD), the growing use of less invasive procedures, and technological developments in balloon catheter design are all major drivers of the North American angioplasty balloons market.

According to the Centers for Disease Control and Prevention (CDC), heart disease is still the top cause of death in the United States accounting for approximately one out of every four deaths. In 2020, around 697,000 persons in the United States died of heart disease. According to the American Heart Association, coronary heart disease alone accounted for 382,820 deaths in 2020. These statistics highlight the region's significant cardiovascular disease burden which drives demand for angioplasty procedures and, as a result, angioplasty balloons. Another important aspect driving market expansion is the aging population in North America.

Asia Pacific:

The Asia Pacific angioplasty balloons market is expanding rapidly, with China emerging as the fastest-growing market due to its large population and rising frequency of cardiovascular illnesses. This trend is projected to continue in the next years driven by several major variables. The increased incidence of cardiovascular disorders, notably coronary artery disease (CAD) is the key driving force behind the Asia Pacific angioplasty balloons market. According to the World Health Organization (WHO), cardiovascular illnesses account for 31% of all fatalities worldwide with a large proportion occurring in low- and middle-income nations many of which are located in the Asia Pacific region.

Another key driver is the improvement of healthcare infrastructure and increased healthcare spending in several Asia Pacific countries. For example, the Australian Institute of Health and Welfare stated that healthcare spending in Australia reached AUD 185.4 billion in 2017-18, up 3.9% from the year before. In Japan, the Ministry of Health, Labour, and Welfare stated that national medical care expenditure totaled JPY 43.4 trillion in fiscal year 2018, up 0.8% over the previous year. The increased usage of minimally invasive procedures such as angioplasty is also driving market expansion. The Indian Council of Medical Research (ICMR) reported a considerable increase in the number of cardiac catheterization facilities across India allowing for more angioplasty treatments.

Global Angioplasty Balloons Market: Segmentation Analysis

The Global Angioplasty Balloons Market is segmented based on Product Type, Application, Packaging Type, and Geography.

Angioplasty Balloons Market, By Product Type

Normal Ballons

Cutting Ballons

Drug-Eluting Balloons

Based on the Product Type, the Global Angioplasty Balloons Market is bifurcated into Normal Ballons, Cutting Ballons, and Drug-Eluting Balloons. The drug-eluting balloons (DEBs) segment is expected to dominate the angioplasty balloons market. DEBs are favored due to their ability to deliver anti-proliferative drugs directly to the arterial wall reducing the risk of restenosis (re-narrowing of the artery) after the procedure. This feature is particularly crucial in complex cases where restenosis is a common concern. The growing preference for minimally invasive treatments and improved patient outcomes further drives the demand for DEBs making them the dominant product type in the market.

Angioplasty Balloons Market, By Application

Coronary Angioplasty

Peripheral Angioplasty

Based on the Application, the Global Angioplasty Balloons Market is bifurcated into Coronary Angioplasty and Peripheral Angioplasty. The coronary angioplasty segment is dominant in the global angioplasty balloons market primarily due to the high prevalence of cardiovascular diseases (CVDs) such as coronary artery disease (CAD). Coronary angioplasty, a procedure to open blocked or narrowed coronary arteries is widely used to restore blood flow to the heart making it a critical treatment for patients with CAD.

Angioplasty Balloons Market, By End-Users

Hospitals

Ambulatory Surgical Centers

Catheterization Laboratories

Based on the End-Users, the Global Angioplasty Balloons Market is bifurcated into Hospitals, Ambulatory Surgical Centers, and Catheterization Laboratories. In the global angioplasty balloons market, the hospital segment is dominant. Hospitals are the primary setting for angioplasty procedures due to their advanced infrastructure, availability of specialized medical personnel, and the ability to handle complex cases. Hospitals often have dedicated cardiac care units and catheterization laboratories making them the preferred choice for both emergency and elective angioplasty procedures. Additionally, hospitals typically manage a higher volume of patients including those with severe or complicated cardiovascular conditions that require immediate intervention, further driving the demand for angioplasty balloons.

Angioplasty Balloons Market, By Geography

North America

Europe

Asia Pacific

Rest of the World

Based on Geography, the Global Angioplasty Balloons Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The North American region dominates the global angioplasty balloons market primarily due to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and widespread adoption of minimally invasive procedures. The presence of leading medical device companies and strong support for research and development further bolster the market. Additionally, North America benefits from favorable reimbursement policies and a well-established regulatory environment that facilitates the approval and use of angioplasty balloons.

Key Players

The "Global Angioplasty Balloons Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation, Cardinal Health, BIOTRONIK, Cook, ENDOCOR GmbH, B. Braun Melsungen AG.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Angioplasty Balloons Market, By Product Type

• Normal Balloons
• Cutting/Scoring Balloons
• Drug-Eluting Balloons (DEB)

5. Angioplasty Balloons Market, By Application

• Coronary Angioplasty
• Peripheral Angioplasty

6. Angioplasty Balloons Market, By End-Users

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Catheterization Laboratories (Cath Labs)

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic
• Boston Scientific Corporation
• Cordis (Cardinal Health)
• Terumo Corporation
• BIOTRONIK

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References